<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38370096</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>Suppl 2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Experience and findings from surveillance peer review in Nigeria, August 2017-May 2019.</ArticleTitle><Pagination><StartPage>9</StartPage><MedlinePgn>9</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2023.45.2.39450</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">acute flaccid paralysis (AFP) surveillance is the gold standard of the Global Polio Eradication Initiative (GPEI) for detecting cases of poliomyelitis and tracking poliovirus transmission. Nigeria's AFP surveillance performance indicators are among the highest in countries of the World Health Organization (WHO) African Region. The primary AFP surveillance performance indicators are the rate of non-polio AFP among children and the proportion of timely, adequate specimen collection. The surveillance working group of the National Emergency Operations Centre assessed the quality of AFP surveillance data in some reportedly high-performing states.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">we conducted a retrospective review of AFP surveillance performance indicators in Nigeria for 2010-2019. We also reviewed data in reports from four groups of surveillance peer reviews and validation visits (conducted by in-country GPEI partners) during August 2017-May 2019 in 16 states with high primary AFP surveillance indicators; the validation visits reviewed clinical information and the dates of specimen collection and onset of paralysis with caretakers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">there were consistently increasing AFP surveillance primary performance indicators during 2010-2016, followed by declines during 2017-2019. From the data for 16 states with peer reviews conducted from August 2017-May 2019, overall concordance of reported and "true" (validated) AFP indicator data in peer review investigations was highly variable. True AFP concordance ranged from 58%-100%, and stool timeliness concordance ranged from 56%-95%. The most common clinical causes of reported AFP cases that were not true AFP were spastic paralysis, malaria, sickle cell disease, and malnutrition. All the states that participated in peer reviews developed surveillance improvement plans based on the gaps identified.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Nigeria has highly sensitive AFP surveillance according to reported primary AFP performance indicators. The findings of peer reviews indicate that the AFP surveillance system needs to be strengthened and well-supervised to enhance data quality.</AbstractText><CopyrightInformation>©Abdullahi Walla Hamisu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamisu</LastName><ForeName>Abdullahi Walla</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>World Health Organization, Nigeria Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etapelong</LastName><ForeName>Sume Gerald</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>World Health Organization, Nigeria Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayodeji</LastName><ForeName>Isiaka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>World Health Organization, Nigeria Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Banda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>World Health Organization, Nigeria Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiona</LastName><ForeName>Braka</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>World Health Organization, Nigeria Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gidado</LastName><ForeName>Saheed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Samuel Luka</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edukugho</LastName><ForeName>Aboyowa Arayuwa</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolu</LastName><ForeName>Omotayo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyelu</LastName><ForeName>Asekun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mawashi</LastName><ForeName>Kabir Yusuf</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Authority, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamu</LastName><ForeName>Usman Said</ForeName><Initials>US</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Authority, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsubuga</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Public Health Solutions, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuaib</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Authority, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Surveillance</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">peer review</Keyword><Keyword MajorTopicYN="N">stool adequacy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38370096</ArticleId><ArticleId IdType="pmc">PMC10874099</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2023.45.2.39450</ArticleId><ArticleId IdType="pii">PAMJ-45-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haenssgen MJ, Closser S, Alonge O. Impact and effect mechanisms of mass campaigns in resourceconstrained health systems: quasi-experimental evidence from polio eradication in Nigeria. BMJ Glob Health. 2021 Mar;6(3):e004248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7942242</ArticleId><ArticleId IdType="pubmed">33685940</ArticleId></ArticleIdList></Reference><Reference><Citation>Leke RG, King A, Pallansch MA, Tangermann RH, Mkanda P, Chunsuttiwat S. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. The Lancet Global Health. 2020 Oct 1;8(10):e1345–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525084</ArticleId><ArticleId IdType="pubmed">32916086</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Jorba J, Greene SA, Diop OM, et al. Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, July 2019-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):489–495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188410</ArticleId><ArticleId IdType="pubmed">32324719</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom JK, Obodai E, Boateng G, Diamenu S, Attiku K, Avevor P, et al. Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases. Hum Vaccin Immunother. 2021 Jul 3;17(7):2117–2124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189041</ArticleId><ArticleId IdType="pubmed">33517832</ArticleId></ArticleIdList></Reference><Reference><Citation>Umeh GC, Shuaib F, Musa A, Tegegne SG, Braka F, Mkanda P, et al. Acute flaccid paralysis (AFP) surveillance intensification for polio certification in Kaduna state, Nigeria: lessons learnt, 2015-2016. BMC Public Health. 2018 Dec 13;18(Suppl 4):1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291918</ArticleId><ArticleId IdType="pubmed">30541509</ArticleId></ArticleIdList></Reference><Reference><Citation>Membo HK, Mweene A, Sadeuh-Mba SA, Masumu J, Yogolelo R, Ngendabanyikwa N, et al. Acute flaccid paralysis surveillance indicators in the Democratic Republic of Congo during 2008-2014. Pan Afr Med J. 2016 Jun 22;24:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012780</ArticleId><ArticleId IdType="pubmed">27642491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I, et al. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect Dis. 2020 Aug 18;20(1):611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="pubmed">32811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yehualashet YG, Mkanda P, Gasasira A, Erbeto T, Onimisi A, Horton J, et al. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S116–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818549</ArticleId><ArticleId IdType="pubmed">26912379</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig K, Fiona B, Banda R, Tegegne SG, Oyetunji A, Obi E, et al. Sensitivity of Acute Flaccid Paralysis Surveillance in Nigeria (2006-2015) J Infect Dis. 2016;2(2):13.</Citation></Reference><Reference><Citation>Adamu US, Archer WR, Braka F, Damisa E, Siddique A, Baig S, et al. Progress Toward Poliomyelitis Eradication-Nigeria, January 2018-May 2019. MMWR Morb Mortal Wkly Rep. 2019 Jul 26;68(29):642–646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660103</ArticleId><ArticleId IdType="pubmed">31344023</ArticleId></ArticleIdList></Reference><Reference><Citation>Raji IA, Abubakar AU, Ahmad A, Gidado S, Olorukooba AA, Lawal BB, et al. Evaluation of Acute Flaccid Paralysis Surveillance indicators in Sokoto State, Nigeria, 2012-2019; A secondary data analysis. BMC Public Health. 2021 Dec;21:1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8207697</ArticleId><ArticleId IdType="pubmed">34130684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim LM, Ningi A, Saleh JE. Performance of Acute Flaccid Paralysis surveillance in Bauchi State, Nigeria, 2016. Online Journal of Public Health Informatics. 2017;9(1)</Citation></Reference><Reference><Citation>Hamisu AW, Johnson TM, Craig K, Mkanda P, Banda R, Tegegne SG, et al. Strategies for Improving Polio Surveillance Performance in the Security-Challenged Nigerian States of Adamawa, Borno, and Yobe During 2009-2014. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S136–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818552</ArticleId><ArticleId IdType="pubmed">26655842</ArticleId></ArticleIdList></Reference><Reference><Citation>Calba C, Goutard FL, Hoinville L, Hendrikx P, Lindberg A, Saegerman C, et al. Surveillance systems evaluation: a systematic review of the existing approaches. BMC Public Health. 2015 May 1;15:448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418053</ArticleId><ArticleId IdType="pubmed">25928645</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahab S. Finding value in the evaluation of public health syndromic surveillance systems from a policy perspective. Alberta, Canada: Alberta Health Services; 2009. Finding value in the evaluation of public health syndromic surveillance systems from a policy perspective; pp. 1–24.</Citation></Reference><Reference><Citation>Anyanwu MO, Akpuh N, Adefisoye A. In-Country Acute Flaccid Paralysis Surveillance Review, Nasarawa State, Nigeria 2017. Online Journal of Public Health Informatics. 2018;10(1):e139.</Citation></Reference><Reference><Citation>National Primary Health Care Development Agency 2020, Nigeria Polio Eradication Emergency Plan. December 2019, Accessed Feb 26 2023.</Citation></Reference><Reference><Citation>Tuma JN, Wilkinson AL, Diop OM, Jorba J, Gardner T, Snider CJ, et al. Surveillance to Track Progress Toward Polio Eradication-Worldwide, 2019-2020. MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):667–673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368747</ArticleId><ArticleId IdType="pubmed">33956779</ArticleId></ArticleIdList></Reference><Reference><Citation>Macama A, Okeibunor J, Grando S, Djibaoui K, Yameogo RK, Morais A, et al. Reasons and circumstances for the late notification of Acute Flaccid Paralysis (AFP) cases in health facilities in Luanda. Pan Afr Med J. 2014 Jul 23;18:239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4242050</ArticleId><ArticleId IdType="pubmed">25426197</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderEnde K, Voorman A, Khan S, Anand A, Snider CJ, Goel A, et al. New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators. Vaccine X. 2020 Mar 21;4:100059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090369</ArticleId><ArticleId IdType="pubmed">32215368</ArticleId></ArticleIdList></Reference><Reference><Citation>Anyanwu MO, Akpuh N, Adefisoye A. In-Country Acute Flaccid Paralysis Surveillance Review, Nasarawa State, Nigeria 2017. Online J Public Health Inform. 2018 May 22;10(1)</Citation></Reference><Reference><Citation>Tangermann RH, Lamoureux C, Tallis G, Goel A. The critical role of acute flaccid paralysis surveillance in the Global Polio Eradication Initiative. Int Health. 2017 May 1;9(3):156–163.</Citation><ArticleIdList><ArticleId IdType="pubmed">28582560</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JC, Diop OM, Gardner T, Chavan S, Jorba J, Wassilak SG, et al. Surveillance to Track Progress Toward Polio Eradication-Worldwide, 2017-2018. MMWR Morb Mortal Wkly Rep. 2019 Apr 5;68(13):312–318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6611474</ArticleId><ArticleId IdType="pubmed">30946737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu AW. Traumatic Injection Neuritis and Acute Flaccid Paralysis Surveillance in Nigeria. Journal of Medical Research and Health Sciences. 2019;2(6):637–642.</Citation></Reference><Reference><Citation>Hamisu AW, Shuaib F, Johnson TM, Craig K, Fiona B, Banda R, et al. Profile of polio-compatible cases in Nigeria, 2006-2016. BMC Public Health. 2018 Dec 13;18(Suppl 4):1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291912</ArticleId><ArticleId IdType="pubmed">30541494</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu AW, Blake IM, Sume G, Braka F, Jimoh A, Dahiru H, et al. Characterizing Environmental Surveillance Sites in Nigeria and Their Sensitivity to Detect Poliovirus and Other Enteroviruses. J Infect Dis. 2022 Apr 19;225(8):1377–1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016446</ArticleId><ArticleId IdType="pubmed">32415775</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson Muluh T, Hamisu AW, Craig K, Mkanda P, Andrew E, Adeniji J, et al. Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012-2015. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S131–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818559</ArticleId><ArticleId IdType="pubmed">26908747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntsama B, Bwaka A, Katsande R, Obiang RM, Oyaole DR, Mkanda P, et al. Polio Data Quality Improvement in the African Region. J Immunol Sci. 2021 Apr 16;(Spec Issue(2)):1105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610762</ArticleId><ArticleId IdType="pubmed">33997861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>